Istari Oncology, Inc., headquartered in Research Triangle Park, North Carolina, is a privately held clinical-stage biotechnology company developing novel immunotherapies for the treatment of glioblastoma and a wide variety of solid tumors. Istari has licensed a broad range of patents and patent applications and has access to additional intellectual property to continue clinical and commercial development of these technologies. The company’s primary asset currently in clinical development is lerapolturev (formerly known as PVSRIPO). For more information, please visit our website.


Meet the Team

Chris (002)

Chris Learn

Sr Director of Clinical Development

Garrett Nichols_June2013 2

Garrett Nichols, MD, MS

Chief Medical Officer

John (002) - Copy

John Higgins

VP Commercial and Corporate Strategy

jess_istari 2

Jess Sorrentino

VP Translational Medicine